257 related articles for article (PubMed ID: 12201824)
1. Screening for macroprolactinaemia and pituitary imaging studies.
Hauache OM; Rocha AJ; Maia AC; Maciel RM; Vieira JG
Clin Endocrinol (Oxf); 2002 Sep; 57(3):327-31. PubMed ID: 12201824
[TBL] [Abstract][Full Text] [Related]
2. Patients with macroprolactinaemia: clinical and radiological features.
Donadio F; Barbieri A; Angioni R; Mantovani G; Beck-Peccoz P; Spada A; Lania AG
Eur J Clin Invest; 2007 Jul; 37(7):552-7. PubMed ID: 17576206
[TBL] [Abstract][Full Text] [Related]
3. Macroprolactinaemia associated with prolactin adenoma.
Mounier C; Trouillas J; Claustrat B; Duthel R; Estour B
Hum Reprod; 2003 Apr; 18(4):853-7. PubMed ID: 12660284
[TBL] [Abstract][Full Text] [Related]
4. Clinical and radiological features of patients with macroprolactinaemia.
Strachan MW; Teoh WL; Don-Wauchope AC; Seth J; Stoddart M; Beckett GJ
Clin Endocrinol (Oxf); 2003 Sep; 59(3):339-46. PubMed ID: 12919157
[TBL] [Abstract][Full Text] [Related]
5. The detection of macroprolactin by precipitation and ultrafiltration methods.
Beda-Maluga K; Pisarek H; Komorowski J; Pawlikowski M; Świętosławski J; Winczyk K
Endokrynol Pol; 2011; 62(6):529-36. PubMed ID: 22144220
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas.
Lewandowski KC; Gasior-Perczak D; Kowalska A; Lewinski A
Gynecol Endocrinol; 2014 May; 30(5):385-7. PubMed ID: 24533748
[TBL] [Abstract][Full Text] [Related]
7. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
Hattori N; Ishihara T; Saiki Y
Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
[TBL] [Abstract][Full Text] [Related]
8. Hyperprolactinaemia does not always mean 'hyperprolactinaemia'!
Gezer A; Atasü T; Hekim C; Stenman UH; Hekim N
Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):206-8. PubMed ID: 15653204
[TBL] [Abstract][Full Text] [Related]
9. Macroprolactin-a cause of pseudohyperprolactinaemia.
Yuen YP; Lai JP; Au KM; Chan AY; Mak TW
Hong Kong Med J; 2003 Apr; 9(2):119-21. PubMed ID: 12668823
[TBL] [Abstract][Full Text] [Related]
10. An audit of the diagnostic usefulness of PRL and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia.
Sawers HA; Robb OJ; Walmsley D; Strachan FM; Shaw J; Bevan JS
Clin Endocrinol (Oxf); 1997 Mar; 46(3):321-6. PubMed ID: 9156042
[TBL] [Abstract][Full Text] [Related]
11. Macroprolactinaemia in diabetic patients.
Gulcelik NE; Usman A
Neuro Endocrinol Lett; 2010; 31(2):270-4. PubMed ID: 20424586
[TBL] [Abstract][Full Text] [Related]
12. Interference by macroprolactin in assays for prolactin: will the
Fahie-Wilson MN; Cobbaert CM; Horvath AR; Smith TP
Clin Chem Lab Med; 2022 Aug; 60(9):1350-1355. PubMed ID: 35704648
[TBL] [Abstract][Full Text] [Related]
13. The TSH response to domperidone reflects the biological activity of prolactin in macroprolactinaemia and hyperprolactinaemia.
Pinto LP; Hanna FW; Evans LM; Davies JS; John R; Scanlon MF
Clin Endocrinol (Oxf); 2003 Nov; 59(5):580-4. PubMed ID: 14616880
[TBL] [Abstract][Full Text] [Related]
14. Reference ranges for serum total and monomeric prolactin for the current generation Abbott Architect assay.
Whitehead SJ; Cornes MP; Ford C; Gama R
Ann Clin Biochem; 2015 Jan; 52(Pt 1):61-6. PubMed ID: 25074991
[TBL] [Abstract][Full Text] [Related]
15. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition.
Olukoga AO; Kane JW
Clin Endocrinol (Oxf); 1999 Jul; 51(1):119-26. PubMed ID: 10468974
[TBL] [Abstract][Full Text] [Related]
16. Determination of prolactin: the macroprolactin problem.
Fahie-Wilson M; Smith TP
Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):725-42. PubMed ID: 24094642
[TBL] [Abstract][Full Text] [Related]
17. Macroprolactin screening in 464 patients with hyperprolactinaemia.
Lim MH; Ho CKM
Malays J Pathol; 2022 Aug; 44(2):261-267. PubMed ID: 36043589
[TBL] [Abstract][Full Text] [Related]
18. Macroprolactin: what is it and what is its importance?
Sadideen H; Swaminathan R
Int J Clin Pract; 2006 Apr; 60(4):457-61. PubMed ID: 16620360
[TBL] [Abstract][Full Text] [Related]
19. Importance of macroprolactinemia in hyperprolactinemia.
Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
[TBL] [Abstract][Full Text] [Related]
20. Hyperprolactinaemia in males: a heterogeneous disorder.
Walsh JP; Pullan PT
Aust N Z J Med; 1997 Aug; 27(4):385-90. PubMed ID: 9448878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
